voriconazole
Generic: voriconazole
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
voriconazole
Generic Name
voriconazole
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
voriconazole 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68462-572
Product ID
68462-572_1c47b796-6b3e-4321-86f6-f51fbf9a39fb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203503
Marketing Start
2015-09-04
Marketing End
2026-11-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462572
Hyphenated Format
68462-572
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
voriconazole (source: ndc)
Generic Name
voriconazole (source: ndc)
Application Number
ANDA203503 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 3 BLISTER PACK in 1 CARTON (68462-572-13) / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 30 TABLET, FILM COATED in 1 BOTTLE (68462-572-30)
- 90 TABLET, FILM COATED in 1 BOTTLE (68462-572-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1c47b796-6b3e-4321-86f6-f51fbf9a39fb", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "upc": ["0368462573303"], "unii": ["JFU09I87TR"], "rxcui": ["349434", "349435"], "spl_set_id": ["4cbac6ad-0faa-4181-a830-27a9f1536b7a"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (68462-572-13) / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "68462-572-13", "marketing_end_date": "20261101", "marketing_start_date": "20150904"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68462-572-30)", "package_ndc": "68462-572-30", "marketing_end_date": "20261101", "marketing_start_date": "20150904"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (68462-572-90)", "package_ndc": "68462-572-90", "marketing_end_date": "20261101", "marketing_start_date": "20150904"}], "brand_name": "voriconazole", "product_id": "68462-572_1c47b796-6b3e-4321-86f6-f51fbf9a39fb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "68462-572", "generic_name": "voriconazole", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "50 mg/1"}], "application_number": "ANDA203503", "marketing_category": "ANDA", "marketing_end_date": "20261101", "marketing_start_date": "20150904"}